See All Slides - tctmd.com

Slides

Presentation AHA 2012

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Presenter: Saurav Chatterjee

November 04, 2012

Presentation AHA 2012

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

Presenter: Eric L. Eisenstein

November 04, 2012

Presentation AHA 2012

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Presenter: Paul A. Gurbel

November 04, 2012

Presentation AHA 2012

FREEDOM Trial Main Results

Presenter: Valentin Fuster

November 04, 2012

Presentation TCT 2012

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Presenter: Bruce Bowers

October 26, 2012

Presentation TCT 2012

Introduction to the TAVR Procedure

Presenter: Martyn Thomas

October 26, 2012

Presentation TCT 2012

Risk-Standardized 30-Day Mortality Rates: What Are They and How Do We Improve Them?

Presenter: Henry Ting

October 26, 2012

Presentation TCT 2012

Strategies for Accurate Valve Placement

Presenter: Martyn Thomas

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

A Well-Calculated Hydration Scheme: The Role of Heart Pressure to Gauge Hydration

Presenter: Somjot Brar

October 26, 2012

Advertisement

Slides

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

FREEDOM Trial Main Results

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Introduction to the TAVR Procedure

Risk-Standardized 30-Day Mortality Rates: What Are They and How Do We Improve Them?

Strategies for Accurate Valve Placement

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

A Well-Calculated Hydration Scheme: The Role of Heart Pressure to Gauge Hydration

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content